Viewing Study NCT05468632


Ignite Creation Date: 2025-12-24 @ 9:30 PM
Ignite Modification Date: 2026-01-01 @ 9:10 PM
Study NCT ID: NCT05468632
Status: COMPLETED
Last Update Posted: 2023-02-14
First Post: 2022-07-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study in North Macedonia Investigating Retrospective Data of Glucagon-like Peptide-1 (GLP-1) Participants With Type 2 Diabetes (T2D) in Real World Environment (RWE) Setting (MIRAGE)
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module